ReviewFrontiers in pharmacology2022

Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations.

Chang-Lin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.